Meyka AI API is live for developers.Start building.
Advertisement
Edesa Biotech, Inc.

Edesa Biotech, Inc. (EDSA) Stock Overview

Explore Edesa Biotech, Inc.’s financial performance, market position, analyst ratings, and future outlook.

EDSA●NASDAQ
HealthcareBiotechnology
$6.27
$0.33(5.56%)
U.S. Market opens in 2h 57m
Advertisement

Edesa Biotech, Inc. (EDSA)

Meyka AI Score

Z

Key Financials

Market Cap57.6M
P/E Ratio-5.16
EPS (TTM)$-1.31
ROE-0.82%
Fundamental Analysis

AI Price Forecasts

1 Month$4.92
3 Months$4.03
1 Year Target$2.92

EDSA Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Edesa Biotech, Inc. (EDSA) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of C+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 41.95, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $2.92.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -5.16 and a market capitalization of 57.6M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
9.09%
5-Day Change
25.10%
1-Month Change
-50.34%
3-Month Change
26.56%
6-Month Change
334.90%
Year-to-Date (YTD) Change
356.34%
1-Year Change
214.56%
3-Year Change
10.20%
5-Year Change
-83.41%
All-Time (Max) Change
-98.90%

Contact Information

https://www.edesabiotech.com
289-800-9600
100 Spy Court, Markham, ON, L3R 5H6

Company Facts

160 Employees
IPO DateJun 21, 2010
CountryCA
Actively Trading

Frequently Asked Questions